The cerebrospinal fluid management market is expected to grow from US$ 1.82 billion in 2021 to US$ 2.61 billion by 2028; it is estimated to grow at a CAGR of 5.3% from 2021 to 2028.

Key factors such as the rising incidence of cerebrospinal fluid (CSF) leaks and growing developments of CSF management products are expected to boost the market growth in the coming years. However, the risk associated with CSF shunts restrains the market growth.

Due to the COVID-19 pandemic, the demand for cerebrospinal fluid management has slumped. The cerebrospinal fluid management market in Asia-Pacific is anticipated to grow at the fastest rate during the forecast period. China and India are major contributors to the market growth, owing to the increasing incidence of CSF leaks and growing developments of CSF management products.

Cerebrospinal Fluid is a fluid found in the brain and spinal cord that safeguards the brain and spinal cord mechanically and immunologically. Various management devices?such as CSF shunts and CSF drainage systems? are used to manage the flow of CSF in the body, away from the ventricles in a controlled manner, thereby preventing the abnormal accumulation of CSF or hydrocephalus. Survival in untreated hydrocephalus is poor. Approximately 50% of the affected patients die before three years of age, and approximately 80% die before reaching adulthood. Treatment significantly improves hydrocephalus outcomes not associated with tumors, with 89% and 95% survival.

The rising prevalence of hydrocephalus eventually boosts the growth of the cerebrospinal fluid management market.

Based on end user, the cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and neurological centers. The hospitals segment held the largest share of the market in 2021. However, the clinics segment is estimated to grow at a CAGR of 5.2% during the forecast period.

Centers for Disease Control and Prevention and the American Association for the Surgery of Trauma are among the major secondary sources referred to while preparing the report on the cerebrospinal fluid management market.